Gufic Biosciences

Gufic Biosciences Limited is a prominent global pharmaceutical firm, ranked among the top 100 in India, providing a wide range of pharmaceutical products and services. Its business is built around four main pillars: Critical Care (life-saving injectables), Assisted Reproductive Technologies (ART), Toxins, and science-based Nutraceuticals to impact global health. The company is committed to being a trusted partner in the field of Assisted Reproductive Technology (ART), providing therapies that enhance the success rates of IVF cycles for families. As a top manufacturer of lyophilized (freeze-dried) injections, its products cover therapeutic areas like antibiotics, antifungals, cardiac medications, and infertility treatments. Strategically, the company focuses on expanding its global presence by targeting key markets like Germany, Switzerland, South Africa, Russia, and other emerging regions. The SPARSH division has established business channels with over 1,400 hospitals across India by the end of FY 2024, demonstrating its strong market penetration.;